Home » Health » Successful Immunization Campaign in Andalusia Against Respiratory Syncytial Virus (RSV)

Successful Immunization Campaign in Andalusia Against Respiratory Syncytial Virus (RSV)

Was the main novelty in the vaccination schedule and its results speak for themselves. The pioneering experience in the world which, together with Galicia, was launched in Andalusia last September to immunize all newborns against the respiratory syncytial virus (RSV), which causes bronchiolitis, is being exit In sevilla. This is clear from the latest data provided to this medium by the Ministry of Health and Consumer Affairsaccording to which, There are currently no babies admitted for bronchiolitis in Sevillian hospitals. Nothing to do with the same dates last year when health centers were practically overwhelmed by the massive arrival of minors suffering from respiratory viruses.

Thus, according to the same sources, while at the beginning of December of last year there were 46 minors hospitalized in Seville for RSV, plus another 12 very seriously ill in the ICU, the highest number of admissions reached this year remained at eight income, one of them in the ICU, quantified in the week of last November 27. That is to say, it can be said that the virus is practically passing through this season. without incident.

The trend repeats itself throughout Andalusiawhere the drop in the number of hospitalizations, both conventional and ICU beds, is 80.82%. In this way, as reported yesterday by the Ministry, on December 12, 2022, there were 245 admissions of minors due to bronchiolitis, of which 48 were in the ICU. The peak, however, was reached in November when 301 minors were admitted at the same time. In total, according to records of the Andalusian Health Service, they were 2,581 children under one year of age who required hospitalization due to RSV last winter. This year’s figures are very far off. With the latest data, corresponding to this same week, there are 47 admissions, of which 11 are in the ICU.

Without a doubt, these are figures of success in the midst of a immunization campaign with very high coverage, above 93%. In total, the campaign includes the immunization of 63,600 babies throughout Andalusia, with an investment of 13.8 million euros. By province, Seville is the territory with the highest number of minors to be immunized, a total of 13,341.

From the Ministry of Health they remember that the campaign will remain active until next April 4, with which they call on all those parents and guardians who have not yet immunized their children to make an appointment to have the dose administered. Immunization is aimed at children born between April 1 and September 30, 2023 (group 1A), at newborns since October 1 (group 1B), as well as the children under one year of age with a history of prematurity of less than 35 weeks (group 2) and other infants with very high-risk chronic pathologies up to 24 months (Group 3). It was activated for the first time in the Andalusian community on September 25 when the first minors received the antibody. nirsevi food (the trade name is Beyfortus).

Respiratory Syncytial Virus (RSV) is the main cause of infections in the lower respiratory tract in children under one year of age, especially those related to bronchiolitis and pneumonia, as well as in the adult population over 65 years of age and in people with medical conditions. risky.

Worldwide, bronchiolitis is the second cause of death in the world in children under one year old. In Spain, RSV infections represent a significant healthcare overload every winter, both in primary care services and in hospitals, including visits to the emergency room, occupancy of hospitalization floors and pediatric intensive care units.

The measure is added to the Annual vaccination against influenza in children from 6 months to 5 years (59 months), which started in Andalusia during the 2022-2023 campaign, with the aim of protecting children as much as possible from the most common respiratory pathologies that present a greater possibility of hospital admission. In the first year of administration of the childhood flu vaccine, more than 45% of the target population has been reached.

2023-12-09 04:05:00
#pioneering #immunization #bronchiolitis #virus #giving #results #Seville

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.